AlphaYouDP
Congress trade
Sen. David Perdue (R-GA) bought $15K-$50K of Merck & Co., Inc. (MRK) stock
David Perdue, U.S. Senator (R-GA), disclosed a purchase of Merck & Co., Inc. (MRK) stock worth $15K-$50K in a STOCK Act filing on Nov 2, 2017.
The trade happened on Oct 27, 2017, 6 days before it was made public.
MRK has moved +159.7% since the trade date, from $55.57 to $144.30 (Oct 2, 2026 close).
- Traded
- Oct 27, 2017
- Disclosed
- Nov 2, 2017
- Filing delay
- 6 days
- Price since
- +159.7%
- Source
- STOCK Act disclosure
Other trades in this disclosure (56)
- SellMYL$15K-$50KNov 2, 2017
- SellQCOM$15K-$50KNov 2, 2017
- BuySLB$15K-$50KNov 2, 2017
- BuyAXTA$1K-$15KNov 2, 2017
- BuyAXTA$1K-$15KNov 2, 2017
- BuyAXTA$1K-$15KNov 2, 2017
- BuyAXTA$1K-$15KNov 2, 2017
- SellBAC$1K-$15KNov 2, 2017
- SellBAC$1K-$15KNov 2, 2017
- SellBAC$1K-$15KNov 2, 2017
- SellCOP$1K-$15KNov 2, 2017
- BuyCOST$1K-$15KNov 2, 2017
- BuyCZR$1K-$15KNov 2, 2017
- BuyCZR$1K-$15KNov 2, 2017
- BuyCZR$1K-$15KNov 2, 2017
- BuyCZR$1K-$15KNov 2, 2017
- SellENTG$1K-$15KNov 2, 2017
- BuyFDC$1K-$15KNov 2, 2017
- BuyFDC$1K-$15KNov 2, 2017
- SellGLW$1K-$15KNov 2, 2017
More MRK insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.